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Congenital hyperinsulinism (CHI; MIM #256450) characterized by an inappropriate over secretion of insulin from pancreatic β-cells is the most frequent cause of persistent hypoglycaemia with an estimated incidence of 1 / 50 000 births in most populations. (1, 2) The clinical challenge concerns patients who are unresponsive to the medical treatment, as severe and persistent hypoglycaemias lead to irreversible brain damage.
CHI is related to different genetic aetiologies. In rare cases, CHI results from anomalies of either the glucokinase (GCK), the glutamate dehydrogenase (GLUD1), shortchain L-3-hydroxyacyl-CoA dehydrogenase (HADH) genes (3 for review) or the hepatocyte nuclear factor 4A (HNF4A), the latter being associated with transient forms of CHI (4), and more recently the monocarboxylate transporter 1 (SLC16A1), which causes exercise-induced HI.(5) However, CHI is mostly associated with molecular defects of the β-cell ATP-sensitive potassium (K ATP ) channel genes, KCNJ11 and ABCC8, respectively encoding the channel subunits Kir6.2 and SUR1. (2, (6) (7) (8) (9) The management of patients depends on the responsiveness to medical therapy. The treatment of CHI is primarily based on the use of diazoxide, a K ATP channel agonist. Since ABCC8 and KCNJ11 defects can impair the channel response to its agonist, (10) another alternative is to use octreotide and frequent or continuous feeding. (11) Pancreatic surgery should be restricted to medically unresponsive CHI. It is therefore essential since their medical care will be different to classify patients correctly according to the two main histopathological forms of CHI. (12) (13) (14) The focal form consists of abnormal pancreatic β-cells restricted to a limited pancreatic area and can be cured by the targeted removal of the pathological tissue. In contrast, the diffuse form affects all the β-cells and thus requires near total pancreatectomy when patients are unresponsive to an intensive medical treatment.
Besides these two well-defined forms of CHI, some histopathological forms are not well-5 characterized, neither being typically focal nor typically diffuse, some of them presenting a mosaicism of their pancreatic β-cells resulting in an atypical form of CHI. (15) (16) (17) Focal and diffuse forms of CHI related to a K ATP channel defect involve distinct molecular mechanisms. Focal forms are sporadic defects resulting from two events: a paternally inherited KCNJ11 or ABCC8 mutation and the loss of the corresponding maternal allele in some pancreatic β-cells leading to a focal lesion. (18, 19) hyperinsulinism-hyperammonemia (HI/HA) syndrome or CHI associated with overgrowth syndromes) were excluded, as each syndrome warrants its specific molecular testing and because they are diazoxide-sensitive. For all studied patients, we obtained the written informed consent in accordance with the French ethical guidelines.
Radiological and histopathological diagnosis
Radiological investigations were based on transhepatic catheterization of the portal and was assessed by analysis of intraoperative frozen samples, formalin fixed and paraffin embedded sections, as described. (12, 15, 27) .
All the pancreatic tissue samples were analysed by two pediatric pathologists, at the time of surgery and before inclusion in this study. We subdivided CHI patients into three radiopathological groups. The first one consisted of 37 patients with a focal form of CHI, 35
of them underwent surgery. The second group included 64 patients with a diffuse form of CHI. In this group, patients were subclassified in "diffuse CHI" (27 operated patients, with pathological confirmation) and "suspected diffuse CHI" (37 patients with radiological diagnosis and no histological confirmation). The third group consisted of 8 operated patients
with an atypical histopathological form as previously described. (17, 28) Median values of clinical characteristics were used for analysis. Categorical data were compared with Fisher exact test. A p value of less than 0.05 was considered of statistical significance.
Genetic analysis
The search for germline events was performed on genomic DNA extracted from peripheral lymphocytes. The study followed five steps:
(i) Sequencing of the coding sequence and exon/intron boundaries of KCNJ11 and ABCC8 genes and the ABCC8 promoter region in probands. In four patients, sequence analysis was also performed on pancreatic DNA extracted from frozen sections to search for somatic events.
( Biosystems) including 6 markers on chromosome 11 in both patient and parents.
(iv) In all probands except those with compound heterozygous mutations, search for ABCC8 genomic rearrangements by multiplex ligation-dependent probe assay (MLPA) (v) GCK screening in patients with no ABCC8 and KCNJ11 mutation.
Sequence analysis
KCNJ11 and ABCC8 sequencing. The sequence analysis included first the amplification by polymerase chain reaction (PCR) of the single exon of KCNJ11, the promoter region of ABCC8 and its 39 exons. The purified PCR products were sequenced in both directions using the ABI PRISM BigDye Terminator chemistry (Applied Biosystems). Sequencing reactions were run on an ABI3100 Genetic Analyzer and analyzed with the Seqscape software Version 2.2 (Applied Biosystems). The mutation nomenclature is based on the reference sequences KCNJ11 NM_000525.3 and ABCC8 NM_000352.3 corresponding to the L72808 isoform (1,582 amino acids) which incorporates the extra serine residue in exon 17. (9) GCK sequencing. The sequence analysis of the coding exons of the pancreatic isoform of GCK (NM_000162.3) was performed for all patients with normal KCNJ11 and ABCC8
investigation.
All primer sequences and amplification conditions are available on request.
MLPA analysis
We used the SALSA MLPA KIT P117 ABCC8 (MRC Holland, The Netherlands) for the search for genomic rearrangements. The procedure was carried out according to manufacturer's instructions. Ligation products were separated on an ABI3730 Genetic 9
Analyzer. The analysis was performed using GeneMapper, Version 4.0 (Applied Biosystems).
Single-exon deletions were checked by real-time quantitative PCR based on SYBR-Green I fluorescence.
Microsatellite marker analysis
A panel of 11 microsatellite markers from the chromosome 11-region around ABCC8 and KCNJ11 (D11S2071, D11S1363, D11S922, D11S2344, D11S2347, D11S1901, D11S419, D11S1397, D11S921, D11S902 and D11S1888) were analyzed on DNA extracted from leucocytes and pancreatic frozen sections. The analysis was performed using GeneMapper, Version 4.0.
RESULTS
We identified a K ATP channel defect in 89 out of 109 probands (81.6%), most of them involving the ABCC8 gene (79/89, 88.8 %). Two mutations were found in 28% (30/109) of the probands, which is therefore consistent with a recessive mode of inheritance (table 1) .
Among them, 11/30 had a homozygous mutation, 5/11 belonging to a consanguineous family and 19/30 patients were compound heterozygotes. In 59 probands (59/109, 54%), a single heterozygous mutation was identified ( patients with a diagnosis of diffuse form proved by histology and those with a diagnosis of diffuse form based on radiological investigation only (table 1) . In patients with a recessive form of CHI, 55% of K ATP mutations were missense mutations whereas 45% were truncating.
In contrast, truncating mutations were less frequently observed in patients carrying a single K ATP heterozygous mutation (23% vs. 45%).
Among the 22 patients with a single heterozygous K ATP channel mutation, 10 had a diagnosis of diffuse CHI confirmed by histology. For 5 of them, the segregation analysis of both parents showed that the mutation had arisen de novo in 2 and was paternally inherited in 3 (table 1) .
To exclude a focal form, we analyzed 11 microsatellite markers in the pancreatic tissue of four patients compared to 2 patients with focal forms and 1 patient with a diffuse form due to 2 mutations. Our results showed a loss of the maternal allele in the two focal forms, as expected, while in the diffuse forms no difference was found between patients with one or two mutations (supplemental material). Futhermore, pathological comparisons between pancreatic specimens from diffuse cases with two mutations and those with one mutation showed the same features characterized by enlarged pancreatic β -cell nuclei throughout the entire pancreas. We also excluded a somatic coding mutation by sequencing ABCC8 and KCNJ11 of pancreatic DNA of these four patients.
In the 12 patients with diffuse form of CHI suspected by PET imaging and carrying a heterozygous ABCC8 mutation, segregation analysis of both parents for 10 cases showed that the mutation had arisen de novo in 1 case, was maternally inherited in 1 and paternally 13 inherited in 8 (table 1) . In the maternally inherited case, several episodes of hypoglycemiarelated seizures in infancy were reported in the mother, although she was asymptomatic at the age of 28. There is strong evidence that the identified mutation Gly716Asp is pathogenic: (i) it is located in the first nucleotide binding domain.
(ii) the same residue was reported to be altered (Gly716Val) in a homozygous recessive form of CHI resistant to diazoxide (30) Last, no ABCC8/KCNJ11 mutation was found in 3 patients with a diagnosis of diffuse form and in 9 with diffuse form suspected by PET (table 1) . One of the operated patients was subsequently found to carry a de novo GCK mutation, c.191C>T; p.Ser64Phe.
Finally, no germline ABCC8/KCNJ11 and GCK mutations were identified in the 8 patients with a histological diagnosis of atypical CHI. Paternal isodisomy at the ABCC8 locus was excluded at the pancreatic level for 3 of them. Since one patient had a monozygotic healthy twin, we also excluded the presence of a somatic mutation.
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DISCUSSION
We have shown that mutations in the ABCC8 and KCNJ11 genes respectively encoding the SUR1 and KIR6.2 subunits of the K ATP channel are major causes of CHI refractory to diazoxide, as they account for 82% of all cases in a large series of 109 patients. This estimate is higher than those previously reported in several series in which a molecular aetiology was found in about 50% to 65% of cases. (2, 8, (32) (33) (34) This discrepancy is probably due to differences in the clinical phenotype of patients, particularly their response to medical treatment, and in the sensitivity of the screening method used for the detection of mutations.
Our study shows that ABCC8 gene defects are the most important cause of diazoxideunresponsive CHI (89% of mutated patients). The mutational spectrum underlines the allelic diversity of ABCC8 and KCNJ11 mutations since 80% of identified molecular events were distinct in this series and half of them were not reported in the recent update of K ATP channel mutations (9) or in subsequent publications. A genomic rearrangement was identified in only two recessive forms of CHI, each one deleting a single exon, demonstrating the rarity of large deletions in CHI.
We classified CHI patients into three groups according to ABCC8/KCNJ11 mutation status (2 recessively inherited mutations, 1 single mutation and no mutation) and investigated the correlation between genotypes and histopathological or radiological diagnosis.
In 28% of patients (30/109), we found recessively inherited mutations, either homozygous or compound heterozygous, all associated with a diagnosis of diffuse form of CHI. Nearly two third of these patients were refractory to all medical treatment and consequently, required near-total pancreatectomy. These patients characterized by a severe clinical presentation were also frequently large for gestational age. Half of them had a birth weight above 4,000 g.
In 54% of patients (59/109), we detected a single mutation in the coding sequence and boundary regions of ABCC8 or KCNJ11. We studied the allelic segregation in 41 families and 15 found that 12% arose de novo, one was maternally inherited and 85% of mutations were paternally inherited. The 37 patients diagnosed with a focal form were all included in this group. This result emphasized the absence of genetic heterogeneity of focal forms of CHI which are exclusively related to functional abnormalities of the K ATP channel. This corroborates our previous results (8, 19) In the third and last group comprising patients with diffuse (n=3), suspected diffuse (n=9) or atypical (n=8) forms, neither a point mutation nor a large rearrangement in ABCC8/KCNJ11
was found. This third group of patients seems to have a less severe phenotype. Only 25%
were large for gestational age and 40% were refractory to octreotide therapy. We screened the GCK gene since three de novo activating GCK mutations have been reported in patients unresponsive to diazoxide. (41, 42) We found one novel de novo GCK mutation which is predicted to be pathogenic and which altered an amino acid previously reported to be the target of a mutation in a patient with CHI. (43) This confirms the low prevalence of GCK activating mutations in severe forms of CHI. Even though the proportion of CHI patients with unexplained molecular aetiology was significantly decreased compared to previous studies, unknown genes remain to be identified in CHI refractory to diazoxide.
Finally, a mosaic paternal uniparental disomy (UPD) has been reported in an "atypical diffuse" form of CHI with a paternally inherited ABCC8 mutation. (17) Contrary to focal forms characterized by a paternal UPD of the 11p15.1-15.5 imprinted region, this atypical form was related to a paternal UPD observed both in DNA from leucocytes and pancreatic tissue but restricted to the 11p15.1 region. We excluded a similar molecular mechanism in our cases of atypical CHI.
In conclusion, 82% of patients with CHI unresponsive to diazoxide were related to ABCC8 or KCNJ11 mutations in our series. The molecular analysis alone provides an informative genetic diagnosis for the clinical management of CHI patients with recessively inherited pathogenic mutations. Genetic counselling and prenatal diagnosis may be offered to families with such previous CHI cases. In contrast, in patients with a single K ATP channel mutation, the molecular analysis should be systematically confronted with the parental segregation analysis and the PET imaging diagnosis. If the mutation is de novo or paternally-inherited and the PET diagnosis in favour of a focal form, the surgery will be offered for the resection of the focal lesion. But, when the PET imaging suspects a diffuse form, the molecular diagnosis has a limited added value for the clinical management of CHI patients.
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